mortality/aging
• non-Mendelian ratios are born (28% wild-type, 55.5% heterozygotes and 16.6% homozygotes)
|
immune system
N |
• lymphoid organs development is normal
|
• IgG1 levels are lower when re-challenged by NP-CGG
|
• IgM levels are decreased during the primary immune response
|
• mice have reduced T-cell-dependent primary immune response to 4-hydroxy-3-nitrophenylacetyl coupled to chicken gamma globulin (NP-CGG)
|
• mice have lower amounts of CD69, a marker of T cell activation
• however, T cell receptor internalization is normal
|
• T cell proliferation in response to anti-CD3-mediated TCR signaling is markedly defective
• however, proliferation in response to phorbol 12-myristate 12-acetate and ionomycin was similar to wild-type in in vivo and in vitro assays
• in vitro challenge of enlarged lymph nodes with NP-CGG produces markedly reduced T cell proliferation
|
• mice produce less IL-2 after anti-CD3 stimulation
• in vitro challenge of enlarged lymph nodes with NP-CGG shows markedly reduced IL-2 production
|
behavior/neurological
growth/size/body
reproductive system
N |
• mice are fertile
|
hematopoietic system
• IgG1 levels are lower when re-challenged by NP-CGG
|
• IgM levels are decreased during the primary immune response
|
• mice have reduced T-cell-dependent primary immune response to 4-hydroxy-3-nitrophenylacetyl coupled to chicken gamma globulin (NP-CGG)
|
• mice have lower amounts of CD69, a marker of T cell activation
• however, T cell receptor internalization is normal
|
• T cell proliferation in response to anti-CD3-mediated TCR signaling is markedly defective
• however, proliferation in response to phorbol 12-myristate 12-acetate and ionomycin was similar to wild-type in in vivo and in vitro assays
• in vitro challenge of enlarged lymph nodes with NP-CGG produces markedly reduced T cell proliferation
|
cellular
• T cell proliferation in response to anti-CD3-mediated TCR signaling is markedly defective
• however, proliferation in response to phorbol 12-myristate 12-acetate and ionomycin was similar to wild-type in in vivo and in vitro assays
• in vitro challenge of enlarged lymph nodes with NP-CGG produces markedly reduced T cell proliferation
|